Life sciences entrepreneurs, researchers and investors working to shape the future of point-of-care medical technologies will gather next week for a free virtual event that will highlight new inventions and connect participants to resources to advance their work.
VIENTIANE (The Vientiane Times/ANN): News that a diabetic woman who contracted Covid-19 had two legs amputated last week because of blood clots has sparked further alarm about the complications that can be caused by the virus.
Singapore develops world-first blood test to monitor cancer treatment success
Singapore develops world-first blood test to monitor cancer treatment success 09 June 2021 | News The ExoSCOPE test accurately classifies disease status and determines treatment outcome within 24 hours after the start of treatment
Image credit- NUS Singapore
Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working, within one day after the start of the treatment.
Assistant Professor Shao Huilin and her research team from the Department of Biomedical Engineering and Institute for Health Innovation & Technology (iHealthtech) at the National University of Singapore (NUS) have developed a technology that is accurate, less invasive and significantly brings forward the evaluation window, by using liquid biopsies.